Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours

Maja de Jonge, H Dumez, Jaap Verweij, S Yarkoni, D Snyder, D Lacombe, S Marreaud, T Yamaguchi, CJA Punt, A van Oosterom

Research output: Contribution to journalArticleAcademicpeer-review

94 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1768-1774
Number of pages7
JournalEuropean Journal of Cancer
Volume42
Issue number12
DOIs
Publication statusPublished - 2006

Research programs

  • EMC MM-03-86-08

Cite this